Sleep Apnea Completed Phase 1 Trials for Suvorexant (DB09034)

Also known as: Sleep apnoeas / Sleep Apnoea / Sleep Apnea Syndrome / Apnea, Sleep / Sleep Apnea Syndromes / Sleep apnoea syndromes / Sleep apnoea syndrome / Apnea syndrome / Apnoea syndrome

IndicationStatusPhase
DBCOND0030087 (Sleep Apnea)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01300455Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036)Treatment